Pharmaceuticals, Biotechnology and Life Sciences
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced there will be one oral presentation…
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced there will be one oral presentation…
OSAKA, Japan & FLORHAM PARK, N.J.–(BUSINESS WIRE)–Shionogi & Co., Ltd. (hereafter “Shionogi”) today announced there will be one oral presentation…
Arena Pharmaceuticals has dosed first patients in a trial called ELEVATE UC 52, which is the first of two pivotal trials within the Phase 3 registrational program designated to test etrasimod 2 mg in subjects with moderately to severely active ulcerative colitis (UC).
AFC will grow its pharmaceutical manufacturing capabilities with advanced technology and refreshed infrastructure, bringing more than 110 new jobs to…
by: Lucy WyndhamYoga can Reduce the Severity of Rheumatoid Arthritis There are over 1.3 million Americans battling rheumatoid arthritis (RA)…
RBM-007 was well-tolerated with no dose-limiting toxicities, no systemic or ocular serious adverse events. Seven out of nine subjects showed…
Encouraging preliminary safety and clinical activity data confirm miransertib’s potential for treating PS and PROS patients Registrational study, MOSAIC (Miransertib…
NEW YORK & SOMERSET, N.J.–(BUSINESS WIRE)–IVERIC bio, Inc. (NASDAQ: ISEE) and Catalent Biologics, today announced that they have entered into…
Acquisition of 16 million additional patient records per annum Creation of new partnerships with laboratories and payers across US, Asia…